Recent and anticipated novel drug approvals (4Q 2025 through 3Q 2026)
Year: 2025
Type: article
DOI: 10.1093/ajhp/zxaf338
Institution: Northwestern Medicine
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W7117871875
